Adicet Bio, Inc. beat EPS estimates 100% of the time across 3 reported quarters (3 beats, 0 misses), averaging +21.0% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $-2.43 | $-1.99 | +18.1% | Beat | |
| Q1 FY26 | $-2.93 | $-1.88 | +35.8% | Beat | |
| Q4 FY25 | $-3.23 | $-2.94 | +9.0% | Beat |
Back to ACET overview · ACET holders · ACET KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.